Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers

NCT01240525 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01240525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01240525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2011
Completion date
November 30, 2019
Enrollment
114 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease, leukemia, lymphoma, myelodysplastic syndrome, myeloma